UNSPSC 51284712: Penoctonium bromide

This classification denotes a topical anti-infective agent with the molecular formula C26H50NO2.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HF11NTT6MZ, chemically known as 1-octanaminium, n-(2-((dicyclopentylacetyl)oxy)ethyl)-n,n-diethyl-, bromide (9ci) but more generally known as penoctonium bromide, which bears US NIH Compound Identifier 71690. European Medicines Agency schedules Penoctonium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09672MIG.

UNSPSC 51284712 Penoctonium bromide is a Commodity code that does not appear to reflect the actual pharmaceutical products and medical supplies being procured under recent state and local solicitations. The code shows little relevant recent activity — the two opportunities posted under this code involve doxycycline hyclate and ciprofloxacin tablets (an antibiotic procurement through Illinois Department of Public Health) and naloxone with drug deactivation systems (a health and safety procurement through Seminole County, Florida), neither of which align with penoctonium bromide or suggest a coherent scope of work under the code's nominal definition. The mismatch between the code name and the actual procurements suggests a tagging or classification inconsistency in the source data.

The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium for $2,999,999.11 over three years (12-month initial term with two renewal options), completed in August 2026 under an Invitation for Bid process. Seminole County, Florida released an IFB in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, under a two-year initial term with one renewal option; the solicitation required electronic bid submission with all shipping and delivery costs included. Neither solicitation applied set-aside designations or domestic product preferences. Without additional opportunities genuinely aligned to the code's nominal scope, the practical business development signal for penoctonium bromide procurement is minimal.